Neurogene Inc expected to post a loss of $1.05 a share - Earnings Preview

Neurogene

07/08/2024 03:55

* Neurogene Inc  NGNE.OQ   NGNE.O  is expected to report
resultson
August 8 (estimated) for the period ending June 30 2024
    * 
    * ​LSEG's mean analyst estimate for Neurogene Inc is for a
loss of
$1.05 per share. 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 7 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Neurogene
Inc is
$51.00​, above​ its last closing price of $37.87. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Mar. 31 2024  -1.12       -1.13      -1.00     Beat    11.9
 Jan. 1 2024   -1.17       -1.17      -1.51     Missed  -28.7
                                      -1.64             ​
                                      -0.80             
 ​​Mar.        -2.51       -2.50      -5.12     Missed  -104.8
 31 2023                                                
 Sep. 30 2022              -3.80      -4.80     Missed  -26.3​
 Sep. 30 2022  -5.94       -6.09      -4.80     Beat    21.1
 Jan. 1 0001   -5.95       -6.00      -5.60     Beat    6.7
 This summary was machine generated August 7 at 02:55 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)